PubMed

Insulin sensitivity and lipid metabolism in human CD36 deficiency.

Furuhashi M, Ura N, Nakata T, Shimamoto K.

Diabetes Care. 2003 Feb;26(2):471-4.PMID: 12547883 [PubMed - indexed for MEDLINE]Related articlesFree article

Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.

Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y.

Diabetes Care. 2000 Dec;23(12):1766-9.PMID: 11128349 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.

Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group.

Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65.PMID: 17283301 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

Diabetes Care. 2002 Jan;25(1):9-15.PMID: 11772894 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease.

Bodlaj G, Berg J, Pichler R, Biesenbach G.

J Nephrol. 2006 Sep-Oct;19(5):607-12.PMID: 17136689 [PubMed - indexed for MEDLINE]Related articles

Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?

Bahceci M, Tuzcu A, Ogun C, Canoruc N, Iltimur K, Aslan C.

J Endocrinol Invest. 2005 Feb;28(2):145-50.PMID: 15887860 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

Meis SB, Schuster D, Gaillard T, Osei K.

Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.

Tan CE, Chew LS, Chio LF, Tai ES, Lim HS, Lim SC, Jayakumar L, Eng HK, Packard CJ.

Diabetes Res Clin Pract. 2001 Feb;51(2):107-14.PMID: 11165690 [PubMed - indexed for MEDLINE]Related articles

Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese.

Kajihara S, Hisatomi A, Ogawa Y, Yasutake T, Yoshimura T, Hara T, Mizuta T, Ozaki I, Iwamoto N, Yamamoto K.

Clin Chim Acta. 2001 Dec;314(1-2):125-30.PMID: 11718687 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Groop L, Ekstrand A, Forsblom C, Widén E, Groop PH, Teppo AM, Eriksson J.

Diabetologia. 1993 Jul;36(7):642-7.PMID: 8359582 [PubMed - indexed for MEDLINE]Related articles

Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.

Reinehr T, Kiess W, Andler W.

Metabolism. 2005 Mar;54(3):397-402.PMID: 15736120 [PubMed - indexed for MEDLINE]Related articles

Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?

Osei K, Rhinesmith S, Gaillard T, Schuster D.

J Clin Endocrinol Metab. 2003 Oct;88(10):4596-601.PMID: 14557428 [PubMed - indexed for MEDLINE]Related articlesFree article

Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea.

Chang SA, Kim HS, Yoon KH, Ko SH, Kwon HS, Kim SR, Lee WC, Yoo SJ, Son HS, Cha BY, Lee KW, Son HY, Kang SK.

Metabolism. 2004 Feb;53(2):142-6.PMID: 14767863 [PubMed - indexed for MEDLINE]Related articles

Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.

Derosa G, Cicero AF, Scalise F, Avanzini MA, Tinelli C, Piccinni MN, Peros E, Geroldi D, Fogari E, D'Angelo A.

Endothelium. 2007 Jan-Feb;14(1):45-51.PMID: 17364896 [PubMed - indexed for MEDLINE]Related articles

Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients.

Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, Yamadori N, Ogura M, Kuroe A, Nakai Y.

Metabolism. 2003 Oct;52(10):1246-9.PMID: 14564674 [PubMed - indexed for MEDLINE]Related articles

The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women.

Crowther NJ, Ferris WF, Ojwang PJ, Rheeder P.

Clin Endocrinol (Oxf). 2006 May;64(5):535-41.PMID: 16649973 [PubMed - indexed for MEDLINE]Related articles

Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.PMID: 15270403 [PubMed - indexed for MEDLINE]Related articles

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.PMID: 17211855 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes.

Tan MH, Johns D, Glazer NB.

Clin Chem. 2004 Jul;50(7):1184-8. Epub 2004 Apr 29.PMID: 15117857 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.

Tan M, Johns D, González Gálvez G, Antúnez O, Fabián G, Flores-Lozano F, Zúñiga Guajardo S, Garza E, Morales H, Konkoy C, Herz M; GLAD Study Group.

Clin Ther. 2004 May;26(5):680-93.PMID: 15220012 [PubMed - indexed for MEDLINE]Related articles